Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6509037
APP PUB NO 20020051817A1
SERIAL NO

09945056

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a novel sustained release composition and method for making such a composition of diclofenac and its pharmaceutically acceptable salts. The composition of the present invention provides a sustained release formulation of diclofenac and pharmaceutically acceptable salts thereof which is suitable for once daily administration and provides controlled and long lasting in vivo release. The composition comprises: (a) about 5-25% by weight of hydroxyethyl cellulose; (b) about 5-75% by weight of lactose; (c) about 0-3% by weight of silicone dioxide; (d) about 0.5-5% by weight of PVP; (e) about <3% by weight of talc; and f) about <3% by weight of magnesium stearate.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHANTILLY BIOPHARMA LLC3701 CONCORDE PARKWAY CHANTILLY VA 20151

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Odidi, Amina 2136 Opal Court, Mississauga, Ontario, CA L5K 2S5 31 963
Odidi, Isa 2136 Opal Court, Mississauga, Ontario, CA L5K 2S5 40 1048

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation